Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Biomarkers for mucositis assessment.

Baggott C.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1169-70. doi: 10.1002/pbc.22258. No abstract available.

PMID:
19731328
2.

Hot topics in postsmall bowel transplantation: noninvasive graft monitoring including stool calprotectin and plasma citrulline.

Mercer DF.

Curr Opin Organ Transplant. 2011 Jun;16(3):316-22. doi: 10.1097/MOT.0b013e3283467115. Review.

PMID:
21505339
3.

[Fecal calprotectin].

Rodrigo L.

Rev Esp Enferm Dig. 2007 Dec;99(12):683-8. Review. Spanish. No abstract available.

4.

Review of fecal biomarkers in inflammatory bowel disease.

Sutherland AD, Gearry RB, Frizelle FA.

Dis Colon Rectum. 2008 Aug;51(8):1283-91. doi: 10.1007/s10350-008-9310-8. Review.

PMID:
18543035
5.

The role of calprotectin in the diagnosis of neonatal necrotising enterocolitis.

Vieten D, Cairns P.

Ir Med J. 2005 Mar;98(3):69. Review. No abstract available.

PMID:
15869060
6.

Mucositis and non-invasive markers of small intestinal function.

Tooley KL, Howarth GS, Butler RN.

Cancer Biol Ther. 2009 May;8(9):753-8. Review.

PMID:
19276675
7.

[Faecal inflammatory markers in nutrition and digestive diseases in children].

Kapel N.

Arch Pediatr. 2004 May;11(5):403-5. Review. French. No abstract available.

PMID:
15135420
8.

Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage.

Foell D, Wittkowski H, Roth J.

Gut. 2009 Jun;58(6):859-68. doi: 10.1136/gut.2008.170019. Review.

PMID:
19136508
9.

[Measurement of calprotectin in faeces].

Jahnsen J, Røseth AG, Aadland E.

Tidsskr Nor Laegeforen. 2009 Apr 16;129(8):743-5. doi: 10.4045/tidsskr.08.0010. Review. Norwegian.

10.

Proteomics for brain disorders--the promise for biomarkers.

Ward M, Güntert A, Campbell J, Pike I.

Ann N Y Acad Sci. 2009 Oct;1180:68-74. doi: 10.1111/j.1749-6632.2009.05018.x. Review.

PMID:
19906262
11.

[Role of biomarkers for risk stratification in the prevention of cardiovascular diseases].

Sinning C, Keller T, Blankenberg S.

Dtsch Med Wochenschr. 2009 Oct;134(40):2019-22. doi: 10.1055/s-0029-1237551. Review. German. No abstract available.

PMID:
19777420
12.

Biomarkers in IBS: when will they replace symptoms for diagnosis and management?

Barbara G, Stanghellini V.

Gut. 2009 Dec;58(12):1571-5. doi: 10.1136/gut.2008.169672. Review. No abstract available.

PMID:
19923339
13.

CSF biomarkers: pinpointing Alzheimer pathogenesis.

Mattsson N, Blennow K, Zetterberg H.

Ann N Y Acad Sci. 2009 Oct;1180:28-35. doi: 10.1111/j.1749-6632.2009.04944.x. Review.

PMID:
19906258
14.

Biomarkers in rheumatologic disease: a review.

Whitt I, Reed A.

Minn Med. 2009 Sep;92(9):38-41. Review.

PMID:
19877477
Items per page

Supplemental Content

Support Center